Cargando…
A Case Series on Pain Accompanying Photoimmunotherapy for Head and Neck Cancer
One of the most severe side effects of photoimmunotherapy (PIT) for head and neck cancer is pain. As there are presently no detailed reports on pain and pain management in PIT, we conducted a retrospective case series study. We conducted a retrospective study of five patients who had received PIT at...
Autores principales: | Shibutani, Yuma, Sato, Haruna, Suzuki, Shinya, Shinozaki, Takeshi, Kamata, Hayato, Sugisaki, Kazuki, Kawanobe, Atushi, Uozumi, Shinya, Kawasaki, Toshikatsu, Hayashi, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048590/ https://www.ncbi.nlm.nih.gov/pubmed/36981581 http://dx.doi.org/10.3390/healthcare11060924 |
Ejemplares similares
-
Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy
por: Shinozaki, Takeshi, et al.
Publicado: (2023) -
Impact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib
por: Suzuki, Shinya, et al.
Publicado: (2020) -
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
por: Tahara, Makoto, et al.
Publicado: (2021) -
Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018) -
A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer
por: Horinouchi, Ai, et al.
Publicado: (2023)